Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors

Bone

Volumn 49, Issue 4, 2011, Pages 693-700

  Fujio, Masahito ^a   Yamamoto, Akihito ^a   Ando, Yuji ^a   Shohara, Ryutaro ^a   Kinoshita, Kazuhiko ^a   Kaneko, Tadashi ^b   Hibi, Hideharu ^a   Ueda, Minoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GC Corporation   (Japan)

Author keywords

Angiogenesis; Bone; Distraction osteogenesis; Endothelial progenitor cells; Regeneration; Stromal cell derived factor 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD VESSEL; BONE MARROW; BONE REGENERATION; CALLUS; CELL MATURATION; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; GAP JUNCTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; BLOOD VESSELS; BONE AND BONES; BONE MARROW CELLS; BONE REGENERATION; BONY CALLUS; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; FEMALE; HUMANS; ISCHEMIA; MICE; MICE, INBRED ICR; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS, DISTRACTION; RECEPTORS, CXCR; RECEPTORS, CXCR4; STEM CELLS; WOUND HEALING;

EID: 80052303159     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.06.024     Document Type: Article

References (49)

1. Ilizarov G.A. Clinical-application of the tension-stress effect for limb lengthening. Clin Orthop Relat Res 1990, 8-26.
2. McCarthy J.G., Stelnicki E.J., Mehrara B.J., Longaker M.T. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg 2001, 107:1812-1827.
3. Samchukov M.L., Makarov M.R., Cherkashin A.M., Birch J.G. Distraction osteogenesis of the orthopedic skeleton: basic principles and clinical applications 2008.
4. Ai-Aql Z.S., Alagl A.S., Graves D.T., Gerstenfeld L.C., Einhorn T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87:107-118.
5. Li G., Simpson A.H., Kenwright J., Triffitt J.T. Effect of lengthening rate on angiogenesis during distraction osteogenesis. J Orthop Res 1999, 17:362-367.
6. Lewinson D., Maor G., Rozen N., Rabinovich I., Stahl S., Rachmiel A. Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system. Histochem Cell Biol 2001, 116:381-388.
7. Jacobsen K.A., Al-Aql Z.S., Wan C., Fitch J.L., Stapleton S.N., Mason Z.D., et al. Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res 2008, 23:596-609.
8. Ilizarov G.A. The tension stress effect on the genesis and growth of tissues. 2. The influence of the rate and frequency of distraction. Clin Orthop Relat Res 1989, 263-285.
9. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
10. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
11. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000, 105:1527-1536.
12. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
13. Wang Y., Wan C., Deng L., Liu X., Cao X., Gilbert S.R., et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007, 117:1616-1626.
14. Riddle R.C., Khatri R., Schipani E., Clemens T.L. Role of hypoxia-inducible factor-1 alpha in angiogenic-osteogenic coupling. J Mol Med 2009, 87:583-590.
15. Carvalho R.S., Einhorn T.A., Lehmann W., Edgar C., Al-Yamani A., Apazidis A., et al. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 2004, 34:849-861.
16. Wan C., Gilbert S.R., Wang Y., Cao X., Shen X., Ramaswamy G., et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 2008, 105:686-691.
17. Petit I., Jin D., Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28:299-307.
18. Salvucci O., Yao L., Villalba S., Sajewicz A., Pittaluga S., Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002, 99:2703-2711.
19. Strasser G.A., Kaminker J.S., Tessier-Lavigne M. Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching. Blood 2010, 115:5102-5110.
20. Tay B.K., Le A.X., Gould S.E., Helms J.A. Histochemical and molecular analyses of distraction osteogenesis in a mouse model. J Orthop Res 1998, 16:636-642.
21. Isefuku S., Joyner C.J., Simpson A.H. A murine model of distraction osteogenesis. Bone 2000, 27:661-665.
22. Kawamoto T. Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch Histol Cytol 2003, 66:123-143.
23. Pacicca D.M., Patel N., Lee C., Salisbury K., Lehmann W., Carvalho R., et al. Expression of angiogenic factors during distraction osteogenesis. Bone 2003, 33:889-898.
24. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
25. Jung Y., Wang J., Schneider A., Sun Y.X., Koh-Paige A.J., Osman N.I., et al. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006, 38:497-508.
26. Allt G., Lawrenson J.G. Pericytes: cell biology and pathology. Cells Tissues Organs 2001, 169:1-11.
27. Gerhardt H., Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003, 314:15-23.
28. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005, 97:512-523.
29. Carano R.A.D., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 2003, 8:980-989.
30. Kanczler J.M., Oreffo R.O.C. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
31. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
32. Lee D.Y., Cho T.J., Kim J.A., Lee H.R., Yoo W.J., Chung C.Y., et al. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone 2008, 42:932-941.
33. Matsumoto T., Mifune Y., Kawamoto A., Kuroda R., Shoji T., Iwasaki H., et al. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 2008, 215:234-242.
34. Bongso A., Fong C.Y., Gauthaman K. Taking stem cells to the clinic: major challenges. J Cell Biochem 2008, 105:1352-1360.
35. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482.
36. Song N., Huang Y., Shi H., Yuan S., Ding Y., Song X., et al. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Cancer Res 2009, 69:6057-6064.
37. De Smet F., Segura I., De Bock K., Hohensinner P.J., Carmeliet P. Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler Thromb Vasc Biol 2009, 29:639-649.
38. Eckardt H., Bundgaard K.G., Christensen K.S., Lind M., Hansen E.S., Hvid I. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res 2003, 21:335-340.
39. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
40. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-894.
41. Smart N., Riley P.R. The stem cell movement. Circ Res 2008, 102:1155-1168.
42. Bladergroen B.A., Siebum B., Siebers-Vermeulen K.G., Van Kuppevelt T.H., Poot A.A., Feijen J., et al. In vivo recruitment of hematopoietic cells using stromal cell-derived factor 1 alpha-loaded heparinized three-dimensional collagen scaffolds. Tissue Eng Part A 2009, 15:1591-1599.
43. Kitaori T., Ito H., Schwarz E.M., Tsutsumi R., Yoshitomi H., Oishi S., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009, 60:813-823.
44. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
45. Morikawa S., Mabuchi Y., Kubota Y., Nagai Y., Niibe K., Hiratsu E., et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009, 206:2483-2496.
46. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
47. Kaigler D., Krebsbach P.H., West E.R., Horger K., Huang Y.C., Mooney D.J. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J 2005, 19:665-667.
48. Magne D., Vinatier C., Julien M., Weiss P., Guicheux J. Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med 2005, 11:519-526.
49. Karsenty G., Kronenberg H.M., Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol 2009, 25:629-648.